- What is OnePass Medical's primary product?
- OnePass Medical's first product is InstaFAN, a biopsy device designed for collecting multiple tissue samples from different areas of a tumor in a single procedure, enhancing diagnostic accuracy and reducing time and repeat biopsies.
- What are the key applications of the InstaFAN platform?
- The InstaFAN platform is particularly strong for endoscopy-ultrasound guided biopsies and bronchoscopies. It also has potential to expand into therapeutic applications, including multipronged drug delivery and ablation.
- What makes OnePass Medical's endoscopic platform unique?
- OnePass Medical's platform is the only endoscopic platform capable of delivering multiple needles/probes simultaneously, which advances both diagnostic and therapeutic capabilities.
- Does OnePass Medical have any strategic collaborations?
- Yes, OnePass Medical has two ongoing strategic development collaborations with Mayo Clinic, both of which include licensing agreements. One collaboration focuses on gastro-intestinal applications of the InstaFAN platform.
- When was OnePass Medical founded?
- OnePass Medical was founded in July 2018.
- How many employees does OnePass Medical have?
- OnePass Medical has 1-10 employees.
- What is OnePass Medical's total funding to date?
- OnePass Medical has raised a total of $3,470,000 USD.
- When was OnePass Medical's most recent funding round?
- OnePass Medical's most recent funding round occurred in July 2021, raising $1,500,000 USD.
- Which investor participated in OnePass Medical's August 2018 funding round?
- G.O Innovation participated in OnePass Medical's August 2018 funding round.
- Has OnePass Medical received any grants?
- Yes, OnePass Medical received a grant of $770,000 USD from the Israel Innovation Authority in April 2021.
